- |||||||||| ADA-011 / Adanate
Enrollment closed, Enrollment change, Trial completion date, Monotherapy, Checkpoint inhibition: A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Sep 19, 2024 P1, N=45, Active, not recruiting, Active, not recruiting --> Terminated; Internal company decision (non-safety related) Recruiting --> Active, not recruiting | N=90 --> 45 | Trial completion date: Dec 2025 --> Dec 2024
- |||||||||| ADA-011 / Adanate
Enrollment open, Monotherapy, Checkpoint inhibition: A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors (clinicaltrials.gov) - Jan 9, 2023 P1, N=90, Recruiting, Recruiting --> Active, not recruiting | N=90 --> 45 | Trial completion date: Dec 2025 --> Dec 2024 Not yet recruiting --> Recruiting
|